December 12, 2020
Join GenesisCare and your colleagues throughout the world for this virtual event focused on emerging indications in stereotactic and MR-guided radiotherapy. Engage in the discussion with colleagues from the likes of Oxford Institute of Radiation Oncology, Action Radiotherapy, GenesisCare UK, Miami Cancer Institute, Acibadem Maslak Hospital Istanbul, Amsterdam UMC, and Washington University. See you there!
Radiotherapy and the COVID Pandemic; UK Experience, Political Advocacy, and Establishing the Global Coalition for Radiotherapy
The Case for Stereotactic Radiotherapy in Primary Kidney Cancer
An introduction to the EMERALD Trial
The Power of Network: Implementing MR-guided SABR in the UK & Beyond
GenesisCare MRL Lung SABR Experience: Including Single Fraction
Two-Year Acibadem Experience with MRIdian
Transforming Radiation Therapy for GI Cancers & Beyond: Novel Applications of MR guidance and adaptive replanning
Oligoprogression Case Discussions
Extreme Hypofractionated MR-Guided Partial Breast Treatments, Clinical Outcomes on MRIdian
November 13, 2020
9:00 AM MT
What treatment options do you offer patients with unresectable renal cell cancer, a disease typically resistant to conventional radiotherapy?
Join Amsterdam University Medical Centers’ Dr. Anna Bruynzeel and Omar Bohoudi, as they share Amsterdam UMC’s advanced approach to radiotherapy for unresectable renal cell cancer (RCC), including breakthrough data on 36 patients with primary RCC treated with 40 Gy/5 fractions using daily adaptive MRIdian SMART.
Anna Bruynzeel, MD, PhD, Radiation Oncologist
Omar Bohoudi, PhD Candidate, Dosimetrist and Radiation Therapist
September 16, 2020
6:00 PM GMT | 11 AM MT
Join us for a multi-disciplinary, multi-institutional webinar uniting some of the best and brightest minds in pancreatic cancer care from the U.S. and U.K. We’ll hear from experts committed to advancing care, offering new treatment options, extending life, and improving quality of life for patients and their families battling this deadly disease.
SPEAKERS AND TOPICS
Staging Pancreas Cancer: A Surgeon’s Perspective
Dr. Keith Roberts, HPB Surgeon, University of Birmingham School of Cancer Sciences, will share an overview of cutting-edge surgical options for pancreas cancer, including a look at borderline resectable cases and the role of radiation in treating these patients
The U.S. Experience Treating Pancreas Cancer on MRIdian
Dr. Michael Bassetti, University of Wisconsin Hospital and Clinics, will share his expertise in SBRT treatment for patients with unresectable disease.
University of Oxford/GenesisCare Compassionate Access Program
Dr. James Good, GenesisCare, will share an overview of their MRIdian SBRT program as well as their groundbreaking collaboration to provide MRIdian treatment at no cost to eligible NHS pancreatic cancer patients who otherwise would not receive treatment. Includes a case review.
MRIdian Vision Presentation
Dr. James F. Dempsey, ViewRay Inc., will share his vision of MRgRT technology and MRIdian.
August 19, 2020
9:00 AM PT
MRgRT offers a new world of cancer care. So, come explore the MR-Linac landscape with a seasoned guide: Dan Low, PhD, Vice-Chair of Medical Physics in the Department of Radiation Oncology at UCLA. Dr. Low will boldly tackle controversial topics like low-field versus high-field; imaging for diagnostics versus therapy delivery; understanding what really matters with gradient systems and imaging sequences; the promise and practice of DWI; and much more – including a Q&A. The goal of this webinar is to arm you with the information you need to make a positive impact on your patients and your practice. Don’t miss out.
Dan Low, PhD, Vice-Chair of Medical Physics, Department of Radiation Oncology UCLA
July 15, 2020
AAPM 2020 Presentation Now On Demand
Join us for a demonstration of the features and functionality that support real-time, on-table, adaptive radiation therapy on the MRIdian system. This presentation includes a demonstration of workflow for an adaptive pancreatic case using real-time tissue tracking and beam gating, as well as time for questions.
July 23, 2020
12:00 PM EST
How did the experts at Dana-Farber/Brigham and Women’s Cancer Center do it?
At a time when the challenges of providing safe treatment to cancer patients crippled the ability to offer care and reduced revenue industry-wide, this program (less than a year old) is on a current run rate to treat ~250 adaptive patients annually, operating at 125% capacity as compared to pre-COVID times, and helping to backstop volume and revenue loss in other areas of the clinic.
Come hear this cross-functional team discuss building, launching, and growing a stunningly successful on-table, adaptive MR-guided radiation therapy program. They’ll share perspectives from leadership on administrative topics, program building, and clinical experience on the toughest-to-treat patients from both medical and physics viewpoints, as well as their approach to patient recruitment. And they’ll still have time for your questions. Join us!
Daphne Haas-Kogan, MD, FASTRO, Chair of the Department of Radiation Oncology
Raymond Mak, MD, Associate Professor of Radiation Oncology
Christopher Williams, PhD, Instructor of Radiation Oncology
Gerard P. Walsh, MBA, Executive Director for Radiation Oncology
July 15, 2020
12:30 PM EST
Save your hardest questions for Dr. Dempsey, who has dedicated his career to solving impossible problems, inventing ingenious technologies and leading the charge in the fight against cancer by revolutionizing radiation therapy for patients worldwide. Don’t miss the chance to catch up with Dr. Dempsey in this Q&A session on the last day of AAPM.
July 14, 2020
12:30 PM ET
What questions do you have for the pioneers at Henry Ford, home of the world’s first MRIdian Linac? With three years of patient treatments under their belts, they are experts on establishing and growing a MRIdian program, creating enough demand from patients and referring physicians to require the installation of a second system. Join Dr. Chetty for this engaging, interactive session.
Indrin J. Chetty, PhD, Professor and Division Head of Medical Physics, Department of Radiation Oncology, Henry Ford Health System
July 13, 2020
12:30 PM EST
Here’s your chance to ask the lead physicist from Brigham and Women’s Hospital anything you want to know about how to successfully launch a MRIdian program, from commissioning to adaptation on their first treatment. They’ve treated more than 100 patients on MRIdian in the first nine months, so now’s the time to get great tips and tricks from the experts in operational excellence.
Christopher Williams, PhD, Chief of MR-Based Adaptive Treatment, Dana-Farber/Brigham and Women’s Cancer Center
July 12, 2020
12:30 PM EST
Bring your questions to two of our best in-house experts in physics and treatment workflow and get the answers you need. This interactive discussion is designed to reveal tips and tricks for using MRIdian and MR guidance to advance patient care, so join Maria and Vito to discuss whatever is on your mind.
June 24, 2020
10:00 AM ET
Safely treating lung tumors with ablative doses can be challenging, from central and ultra central to single fraction requires a new level of precision and accuracy. See how Amsterdam University Medical Center is using MRIdian to treat smarter with ablative doses that work harder to destroy tumors and spare healthy tissues. Join this webinar where they will share their experience treating lung cancer with single fraction SABR. With the potential to improve outcomes, reduce side effects and deliver better patient quality of life, is this the future of cancer care? Come see what you may be missing.
Prof. Suresh Senan, MD, Professor of Clinical Experimental Radiotherapy
Miguel Palacios, PhD, Medical Physicist
June 8, 2020
6:00 PM EST
Please join us to hear from the Radiation Oncology department at UCLA Health on the overall impact COVID-19 may have on the practice of radiation oncology therapy moving forward. Learn how their team is leveraging MRIdian and adapting patient care to offer fewer fractions and ablative doses, including a case study on prostate SBRT. Drs. Steinberg and Kishan will also offer an overview of their MRIdian program and topline the promising clinical trials underway at UCLA that have the potential to reshape patient treatment in the future
Dr. Michael Steinberg, Professor and Chair, Department of Radiation Oncology
Dr. Amar Kishan, Assistant Professor
June 3, 2020
1:00 PM EST
With cancer treatment centres in Australia, Spain, the United Kingdom and now the United States, GenesisCare is the world’s largest private provider of radiotherapy. Working in collaboration with the University of Oxford, GenesisCare has brought the UK’s first MRIdian MR-guided facility to the UK.
On this webinar, the team will be discussing the insights gained during the MRIdian implementation process and from treating their first 50 patients, leveraging MR-guided radiotherapy and adapting patient care to a rapidly changing cancer landscape. Hear about the role of SABR as an alternative to surgery and chemotherapy for urological and hepatobiliary cancers, and in the setting of reirradiation.
Dr. James Good, Clinical Director of SBRT
Dr. Philip Camilleri, Clinical Director of Urology
Dr. Veni Ezhil, Specialist SBRT Advisor
May 13, 2020
10:00 AM EST
Please join us to hear how the radiation oncology team at Turkey’s Acibadem Maslak Hospital adapted patient care and departmental procedures amidst COVID-19, leveraging MRIdian to offer fewer fractions and ablative doses in a time when surgery and chemo are not available to all. Learn about the advantages of SBRT and MRIdian during a crisis and how this may reshape the future of cancer care in a rapidly changing cancer care landscape.
Dr. Enis Ozyar, Professor of Radiation Oncology
Dr. Banu Atalar, Professor of Radiation Oncology
Gorkem Gungor, Senior Medical Physics Expert
May 6, 2020
11:45 AM EST
How did Italy’s frontline, Gemelli ART, respond to the COVID-19 pandemic? Hear how they adapted patient care and departmental procedures in radiation oncology to reduce patient encounters with the hospital system, leveragingMRIdian to offer fewer fractions and ablative doses in a time when surgery and chemo were not available to all. Learn how SBRT and MRIdian are reshaping the future of cancer care in a rapidly changing cancer care landscape.
Luca Boldrini, MD; Medical Director, Radiation Oncologist
Davide Cusumano, PhD; Medical Physicist
April 22, 2020
Join us on Wednesday, April 22 at 4 PM EST as we learn how Miami Cancer Institute, Baptist Health South Florida has adapted patient care and departmental procedures during the COVID-19 pandemic, with a special focus on the role of radiation oncology and SBRT during this time of crisis. We’ll discuss best practices, swap ideas and plan together for the future.
Dr. Minesh Mehta, Deputy Director, Chief of Radiation Oncology
Dr. Michael Chuong, Director of MR-Guided Radiation Therapy and Proton Therapy
Alonso Gutierrez, Chief of Medical Physics
September 20, 2018
Learn about MRI-Guided RT technology as it relates to managing tumor motion and delivering precise radiation therapy. Speakers from NewYork-Presbyterian Hospital / Weill Cornell Medicine and University of Wisconsin-Madison share their clinical experience with continuous, high-quality soft tissue visualization and automated beam-gating on MRIdian.
Watch the recorded webinar by registering on Imaging Technology News (ITN).
July 26, 2018
Learn about the rationale and workflow for modifying radiation therapy treatments while the patient is on the table using Real-time On-table Adaptive Radiotherapy (ROAR). Speakers from Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine, and Amsterdam University Medical Center share clinical cases.
Watch the recorded webinar on IOP Publishing / Physics World. Register via BrightTalk.